Skip to main content

Table 2 Laboratory results of the patient

From: Patient with multiple acyl-CoA dehydrogenase deficiency disease and ETFDH mutations benefits from riboflavin therapy: a case report

Tests Results Reference index Units
Albumin 38 35–48 g/L
Alanine transferase 37 17–63 U/L
Alkaline phosphatase 46 38–126 U/L
Bilirubin 12 7–31 umol/L
Calcium 2.28 2.15–2.58 mmol/L
Carnitine, serum
 Carnitine, total 47 34–78 nmol/ml
 Carnitine, free (FC) 28 25–54 nmol/ml
 Acylcarnitine (AC) 19 5–30 nmol/ml
 AC/FC Ratio 0.7 0.1–0.8  
Creatinine 66 60–105 umol/L
Creatinine kinase 492 50–250 U/L
Glucose, fasting 6.0 3.0–6.0 mmol/L
Glycated Hemoglobin 6.4 %
Lipid Panel
 Cholesterol 5.2   mmol/L
 HDL-C 1.4   mmol/L
 LDL-C 3.4   mmol/L
 Triglycerides 0.9   mmol/L
Myoglobin 294 16–96 ug/L
Riboflavin, serum 6 1–19 ug/L
Thyroxine, free 13 8–21 pmol/L
TSH 2.69 0.34–5.60 mIU/L
25-OH vitamin D 24 > 20 ug/L
  1. Numbers out of reference index are in bold